Logo
x

Search category

Subscribe Now

Shanghai Henlius

Henlius and Organon Report the P-III Study Results of HLX14 (Biosimilar, Denosumab)

Henlius and Organon Report the P-III Study Results of HLX14 (Biosimilar, Denosumab)

  • April 8, 2024
Shanghai Henlius Reports P-III Placebo-Controlled Trial Results of HLX01 (biosimilar, rituximab) for Active Rheumatoid Arthritis

Shanghai Henlius Reports P-III Placebo-Controlled Trial Results of HLX01 (biosimilar, rituximab) for Active Rheumatoid Arthritis

  • October 10, 2022
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.